Abstract B079: Disparities in treatment receipt and reasons for non-treatment in advanced gastrointestinal cancers
TL;DR
Pat, socioeconomic, and healthcare factors were associated with both non-receipt of cancer-directed treatment and reasons for non-treatment among patients with advanced GIC, suggesting that potentially modifiable healthcare access and care delivery factors may contribute substantially to treatment non-receipt.
Abstract
Gastrointestinal cancers (GIC) account for substantial morbidity and mortality, yet a significant proportion of patients do not receive cancer-directed treatment. The reasons underlying non-treatment remain poorly characterized. We evaluated factors associated with non-receipt of treatment and, among untreated patients, factors associated with reasons for non-treatment. We conducted a retrospective cohort study using the National Cancer Database (NCDB), including adults with stage III–IV colon, esophageal, liver, pancreatic, rectal, and gastric cancers diagnosed from 2016–2023 (N=487,414). Treatment status was defined as receipt of ≥1 cancer-directed modality versus no treatment. Among untreated patients (n=113,031), reasons for non-treatment were classified as contraindication/death, refusal, or not planned. Two nested analyses evaluated: (1) clinical (contraindication/death) versus non-clinical reasons and (2) refusal versus treatment not planned among patients without documented clinical reasons. Missing data were addressed using multiple imputation. Multivariable generalized estimating equation logistic regression models estimated adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Overall, 23.2% of patients did not receive cancer-directed treatment. Compared with patients aged 18–49 years, the odds of non-treatment increased with age, reaching more than fourfold higher among those aged ≥75 years (OR 4.24, 95% CI 4.07–4.43). Compared with privately insured patients, uninsured (OR 2.34, 95% CI 2.19–2.49), Medicaid-insured (OR 1.53, 95% CI 1.49–1.57), and Medicare-insured patients (OR 1.30, 95% CI 1.27–1.34) had higher odds of non-treatment. Non-Hispanic Black patients had higher odds of non-treatment than Non-Hispanic White patients (OR 1.14, 95% CI 1.11–1.17). Among untreated patients, 20.7% had contraindication/death, 12.5% refused treatment, and 66.8% had treatment not planned. Among untreated patients, Non-Hispanic Black patients had higher odds of a documented clinical reason for non-treatment (OR 1.20, 95% CI 1.14–1.25), whereas female (OR 0.94, 95% CI 0.91–0.97) and uninsured patients (OR 0.87, 95% CI 0.80–0.95) had lower odds. Among patients without clinical reasons, older age and women had greater odds of treatment refusal, while Hispanic (OR 0.91, 95% CI 0.84–0.97) and Non-Hispanic Black patients (OR 0.79, 95% CI 0.75–0.84) had lower odds of refusal versus treatment not planned. Patient, socioeconomic, and healthcare factors were associated with both non-receipt of cancer-directed treatment and reasons for non-treatment among patients with advanced GIC. Distinct patterns were observed for clinical versus non-clinical reasons for non-treatment. Notably, most untreated patients had treatment not planned rather than documented contraindications/death or treatment refusal, suggesting that potentially modifiable healthcare access and care delivery factors may contribute substantially to treatment non-receipt. Maira A. Castañeda-Avila, Jonggyu Baek, Tasneem Ali, Raiya A. Suliman, Akua Serebou, Kate L. Lapane. Disparities in treatment receipt and reasons for non-treatment in advanced gastrointestinal cancers [abstract]. In: Proceedings of the 19th AACR Conference on the Science of Cancer Health Disparities; 2026 Oct 18-21; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2026;35(10 Suppl):Abstract nr B079.